Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer

BACKGROUND: Novel biomarkers and molecular monitoring tools hold potential to improve outcome for patients following resection of pancreatic ductal adenocarcinoma (PDAC). We hypothesized that the combined longitudinal analysis of mutated cell-free plasma KRAS (cfKRAS(mut)) and CA 19–9 during adjuvan...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussung, Saskia, Akhoundova, Dilara, Hipp, Julian, Follo, Marie, Klar, Rhena F. U., Philipp, Ulrike, Scherer, Florian, von Bubnoff, Nikolas, Duyster, Justus, Boerries, Melanie, Wittel, Uwe, Fritsch, Ralph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802224/
https://www.ncbi.nlm.nih.gov/pubmed/33430810
http://dx.doi.org/10.1186/s12885-020-07736-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802224/
https://www.ncbi.nlm.nih.gov/pubmed/33430810
http://dx.doi.org/10.1186/s12885-020-07736-x

Ejemplares similares